Dengke Pan

Dr. Dengke Pan


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2025 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JHJianxing He
Jianxing He
JSJiang Shi
Jiang Shi
CYChao Yang
Chao Yang
GPGuilin Peng
Guilin Peng
CJChunrong Ju
Chunrong Ju
XXXin Xu
Xin Xu

11 November 2021 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
BXBaocai Xie
Baocai Xie
XSXiaochen Shi
Xiaochen Shi
YLYan Li
Yan Li
BXBo Xia
Bo Xia
JZJia Zhou
Jia Zhou
JWJang-Wei Wu
Jang-Wei Wu
Genetic variants in the asialoglycoprotein receptor 1 (ASGR1) are associated with a reduced risk of cardiovascular disease (CVD) in humans. However, the underlying molecular mechanism remains elusive. Given the cardiovascular similarities between pigs and humans, we generated ASGR1-deficient pigs using the CRISPR/Cas9 system. These pigs show age-dependent low levels of non-HDL-C under standard diet. When received an atherogenic diet for 6 months, ASGR1-deficient pigs show lower levels of non-HDL-C and less atherosclerotic lesions than that of controls. Furthermore, by analysis of hepatic transcriptome and in vivo cholesterol metabolism, we show that ASGR1 deficiency reduces hepatic de novo cholesterol synthesis by downregulating 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), and increases cholesterol clearance by upregulating the hepatic low-density lipoprotein receptor (LDLR), which together contribute to the low levels of non-HDL-C. Despite the cardioprotective effect, we unexpectedly observed mild to moderate hepatic injury in ASGR1-deficient pigs, which has not been documented in humans with ASGR1 variants. Thus, targeting ASGR1 might be an effective strategy to reduce hypercholesterolemia and atherosclerosis, whereas further clinical evidence is required to assess its hepatic impact.

17 July 2017 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
ZZZhuochao Zhang
Zhuochao Zhang
XLXiao Li
Xiao Li
HZHong Zhang
Hong Zhang
XZXuan Zhang
Xuan Zhang
HCHui Chen
Hui Chen
KDKefeng Dou
Kefeng Dou

29 March 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
HFHao Feng
Hao Feng
TLTao Li
Tao Li
JDJiaxiang Du
Jiaxiang Du
QXQiangbing Xia
Qiangbing Xia
LWLu Wang
Lu Wang
GCGang Chen
Gang Chen
Sda, produced by the B4GALNT2 enzyme, has been recognized as an important xenoantigen for pig-to-nonhuman primate xenotransplantation. However, little is known about Sda expression in pigs and its immunogenicity in xenotransplantation. In this study, peripheral blood mononuclear cells (PBMCs) were isolated from wildtype, GTKO (with high, moderate, and low Sda expression), GTKO/β4GalNT2KO, GTKO/CMAHKO, or GTKO/CMAHKO/β4GalNT2KO pigs. Anti-pig IgM/IgG binding and complement-dependent cytotoxicity (CDC) to pig PBMCs was measured by flow cytometry using pooled rhesus monkey sera (n=20) or human sera (n=20). As compared to wild-type pigs (n=12), GTKO pigs (n=17) had a significantly higher mean level of Sda expression on PBMCs and showed a greater individual difference in expression. Both the overall binding of monkey serum IgM/IgG antibody to GTKO pig PBMCs and CDC against these PBMCs decreased significantly with a progressive reduction in Sda expression, showing a clear dose-effect relationship. Both the monkey serum antibody binding and CDC decreased significantly after the additional deletion of Sda, whereas the binding of human serum antibody and CDC against the GTKO pig PBMCs were markedly reduced after the deletion of Neu5Gc in the pigs. In addition, anti-Sda antibody accounted for > 50% of the induced anti-non-Gal antibody at the time of rejection in two rhesus monkeys that received GTKO/hCD55 pig kidney xenotransplantation, and the anti-Sda antibody showed significant cytotoxic activity against GTKO pig cells. We conclude that both natural and induced anti-Sda antibodies play important roles in GTKO pig-to-rhesus monkey xenotransplantation, thus providing further evidence for GTKO/β4GalNT2KO pigs as the preferred organ source for rhesus monkeys as a preclinical model of xenotransplantation.

18 December 2018 in Cell Discovery
Verified
Journal Article
Open access
PDF file
ZLZhifang Li
Zhifang Li
XDXiaoyue Duan
Xiaoyue Duan
XAXiaomeng An
Xiaomeng An
TFTao Feng
Tao Feng
PLPan Li
Pan Li
SWSen Wu
Sen Wu

30 July 2025 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TKTao Kaishan
Tao Kaishan
YLYu-Wei Ling
Yu-Wei Ling
XZXuan Zhang
Xuan Zhang
ZYZhao-Xu Yang
Zhao-Xu Yang
HZHong-Tao Zhang
Hong-Tao Zhang
LWLin Wang
Lin Wang